LBBW Aktienanleihe DAX 27.02.2026/ DE000LB422N4 /
15/05/2024 13:17:21 | Var.+0.07 | Denaro13:30:01 | Lettera13:30:01 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
100.15EUR | +0.07% | 100.15 Quantità in denaro: 250,000 |
100.25 Quantità in lettera: 250,000 |
DAX | 16,500.00 EUR | 27/02/2026 | Call |
GlobeNewswire
13:32
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
GlobeNewswire
13:30
PDD Holdings to Report First Quarter 2024 Unaudited Financial Results on May 22, 2024
GlobeNewswire
13:30
CORRECTION – Dragonfly Energy Reports First Quarter 2024 Financial and Operational Results
GlobeNewswire
13:30
DeFi Technologies Subsidiary Valour Inc. Launches World's First Yield Bearing Bitcoin (BTC) ETP in C...
GlobeNewswire
13:30
Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with ...
GlobeNewswire
13:30
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with To...
GlobeNewswire
13:30
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology...
GlobeNewswire
13:30
AppTech Payments Corp. Reports Strong Start to 2024 with Positive First Quarter Financial Results an...
GlobeNewswire
13:30
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress